(Q66886853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

Cell-mediated immunity in patients with carcinoma.Correlation between clinical stage and immunocompetence (English)

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

7 September 2023

main subject

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085193

7 September 2023

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

7 September 2023

author name string

S. Kopersztych

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085193

7 September 2023

M. T. Rezkallah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085193

7 September 2023

S. S. Miki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085193

7 September 2023

C. K. Naspitz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085193

7 September 2023

N. F. Mendes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085193

7 September 2023

language of work or name

English

0 references

publication date

1 September 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

7 September 2023

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

7 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

1149-1154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

Effect of homologous plasma on lymphocyte transformation in cancer patients and controls.

31 August 2019

cites work

1

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology

7 September 2023

2

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

7 September 2023

3

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Some Methods for Strengthening the Common χ 2 Tests

7 September 2023

5

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Impaired immunologic reactivity and recurrence following cancer surgery

7 September 2023

6

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Immunologic abnormalities in head and neck cancer.

7 September 2023

7

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Effect of serum from cancer patients on homologous lymphocyte cultures

7 September 2023

8

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Risk of cancer in renal-transplant recipients.

7 September 2023

9

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry.

7 September 2023

11

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

The response to phytohaemagglutinin (PHA) of lymphocytes from cancer patients

7 September 2023

12

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer

7 September 2023

13

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

7 September 2023

14

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Suppression of the mitogenic response to phytohemagglutinin in malignant neoplasia: correlation with clinical stage and therapy

7 September 2023

15

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Cell-mediated immunity in leprosy and transfer of delayed hypersensitivity reactions.

7 September 2023

16

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

T and B lymphocyte membrane markers in cells from patients with leukemia and lymphoma

7 September 2023

18

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Recent Advances in Oncology

7 September 2023

20

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells

7 September 2023

21

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other Diseases

7 September 2023

25

1 reference

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197609)38:3%3C1149::AID-CNCR2820380316%3E3.0.CO;2-X

7 September 2023

Identifiers

10.1002/1097-0142(197609)38:3<1149::AID-CNCR2820380316>3.0.CO;2-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085193%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference